Getachew, Y., Cusimano, F. A., Gopal, P., Reisman, S. A., & Shay, J. W. (2016). The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury. Toxicol Sci.
Chicago Style aipamenaGetachew, Yonas, Frank A. Cusimano, Purva Gopal, Scott A. Reisman, and Jerry W. Shay. "The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury." Toxicol Sci 2016.
MLA aipamenaGetachew, Yonas, et al. "The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury." Toxicol Sci 2016.